Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Gyre Therapeutics, Inc. (GYRE) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Gyre Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1124105.
Total stock buying since 2015: $151,110.
Total stock sales since 2015: $4,624,331.
Total stock option exercises since 2015: $1,031,137.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 115,550 | $1,305,047 | 715,000 | $628,950 |
| 2024 | 0 | $0 | 48,285 | $715,698 | 43,452 | $301,122 |
| 2022 | 19,500 | $9,066 | 0 | $0 | 0 | $0 |
| 2021 | 4,921 | $20,492 | 0 | $0 | 5,000 | $23,150 |
| 2020 | 15,850 | $75,374 | 69,401 | $423,484 | 0 | $0 |
| 2019 | 1,000 | $8,029 | 0 | $0 | 8,800 | $40,744 |
| 2018 | 0 | $0 | 71,951 | $2,180,102 | 8,029 | $37,171 |
| 2015 | 19,000 | $38,149 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-05 | 0 | $0 | 18,760 | $204,428 | 0 | $0 |
| 2025-04 | 0 | $0 | 0 | $0 | 65,000 | $141,450 |
| 2025-03 | 0 | $0 | 26,416 | $294,892 | 650,000 | $487,500 |
| 2025-02 | 0 | $0 | 37,878 | $449,504 | 0 | $0 |
| 2025-01 | 0 | $0 | 32,496 | $356,223 | 0 | $0 |
| 2024-12 | 0 | $0 | 4,000 | $45,450 | 0 | $0 |
| 2024-06 | 0 | $0 | 3,452 | $41,437 | 3,452 | $23,922 |
| 2024-05 | 0 | $0 | 20,000 | $295,940 | 20,000 | $138,600 |
| 2024-04 | 0 | $0 | 20,000 | $323,000 | 20,000 | $138,600 |
| 2024-01 | 0 | $0 | 833 | $9,871 | 0 | $0 |
| 2022-08 | 9,750 | $4,581 | 0 | $0 | 0 | $0 |
| 2022-02 | 9,750 | $4,485 | 0 | $0 | 0 | $0 |
| 2021-08 | 2,669 | $9,661 | 0 | $0 | 0 | $0 |
| 2021-04 | 0 | $0 | 0 | $0 | 5,000 | $23,150 |
| 2021-02 | 2,252 | $10,831 | 0 | $0 | 0 | $0 |
| 2020-08 | 2,350 | $11,303 | 0 | $0 | 0 | $0 |
| 2020-03 | 10,500 | $45,378 | 0 | $0 | 0 | $0 |
| 2020-02 | 3,000 | $18,693 | 69,401 | $423,484 | 0 | $0 |
| 2019-05 | 1,000 | $8,029 | 0 | $0 | 8,800 | $40,744 |
| 2018-11 | 0 | $0 | 173 | $1,903 | 322 | $1,489 |
| 2018-05 | 0 | $0 | 0 | $0 | 7,560 | $35,002 |
| 2018-04 | 0 | $0 | 0 | $0 | 88 | $407 |
| 2018-03 | 0 | $0 | 71,778 | $2,178,199 | 59 | $273 |
| 2015-12 | 19,000 | $38,149 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-28 | Ma Songjiang (President) | Sale | 558 | 10.07 | 5,619 |
| 2025-05-27 | Ma Songjiang (President) | Sale | 2,000 | 10.28 | 20,560 |
| 2025-05-23 | Ma Songjiang (President) | Sale | 182 | 10.24 | 1,863 |
| 2025-05-22 | Ma Songjiang (President) | Sale | 2,000 | 10.97 | 21,940 |
| 2025-05-21 | Ma Songjiang (President) | Sale | 2,000 | 10.83 | 21,660 |
| 2025-05-20 | Ma Songjiang (President) | Sale | 2,000 | 11.25 | 22,500 |
| 2025-05-19 | Ma Songjiang (President) | Sale | 2,000 | 11.11 | 22,220 |
| 2025-05-16 | Ma Songjiang (President) | Sale | 2,000 | 11.31 | 22,620 |
| 2025-05-15 | Ma Songjiang (President) | Sale | 2,000 | 10.68 | 21,360 |
| 2025-05-14 | Ma Songjiang (President) | Sale | 20 | 11.30 | 226 |
| 2025-05-13 | Ma Songjiang (President) | Sale | 2,000 | 11.37 | 22,740 |
| 2025-05-12 | Ma Songjiang (President) | Sale | 2,000 | 10.56 | 21,120 |
| 2025-04-16 | Eastling Thomas Wilson | Option Ex | 15,000 | 6.93 | 103,950 |
| 2025-04-01 | Ye Weiguo (Chief Operating Officer) | Option Ex | 50,000 | .75 | 37,500 |
| 2025-03-27 | Ye Weiguo (Chief Operating Officer) | Option Ex | 150,000 | .75 | 112,500 |
| 2025-03-26 | Ye Weiguo (Chief Operating Officer) | Option Ex | 200,000 | .75 | 150,000 |
| 2025-03-24 | Ye Weiguo (Chief Operating Officer) | Option Ex | 300,000 | .75 | 225,000 |
| 2025-03-21 | Ma Songjiang (President) | Sale | 174 | 10.00 | 1,740 |
| 2025-03-20 | Ma Songjiang (President) | Sale | 2,000 | 10.09 | 20,180 |
| 2025-03-19 | Ma Songjiang (President) | Sale | 2,000 | 10.13 | 20,260 |
| 2025-03-18 | Ma Songjiang (President) | Sale | 242 | 10.24 | 2,478 |
| 2025-03-17 | Ma Songjiang (President) | Sale | 2,000 | 12.09 | 24,180 |
| 2025-03-14 | Ma Songjiang (President) | Sale | 2,000 | 12.31 | 24,620 |
| 2025-03-13 | Ma Songjiang (President) | Sale | 2,000 | 11.80 | 23,600 |
| 2025-03-12 | Ma Songjiang (President) | Sale | 2,000 | 11.74 | 23,480 |
| 2025-03-11 | Ma Songjiang (President) | Sale | 2,000 | 11.40 | 22,800 |
| 2025-03-10 | Ma Songjiang (President) | Sale | 2,000 | 10.14 | 20,280 |
| 2025-03-07 | Ma Songjiang (President) | Sale | 2,000 | 11.77 | 23,534 |
| 2025-03-06 | Ma Songjiang (President) | Sale | 2,000 | 10.80 | 21,600 |
| 2025-03-05 | Ma Songjiang (President) | Sale | 2,000 | 10.98 | 21,960 |
| 2025-03-04 | Ma Songjiang (President) | Sale | 2,000 | 10.86 | 21,720 |
| 2025-03-03 | Ma Songjiang (President) | Sale | 2,000 | 11.23 | 22,460 |
| 2025-02-28 | Ma Songjiang (President) | Sale | 2,000 | 11.41 | 22,820 |
| 2025-02-27 | Ma Songjiang (President) | Sale | 2,000 | 11.33 | 22,660 |
| 2025-02-26 | Ma Songjiang (President) | Sale | 2,000 | 11.63 | 23,260 |
| 2025-02-25 | Ma Songjiang (President) | Sale | 2,000 | 11.37 | 22,740 |
| 2025-02-24 | Ma Songjiang (President) | Sale | 2,000 | 11.06 | 22,120 |
| 2025-02-21 | Ma Songjiang (President) | Sale | 2,000 | 12.22 | 24,440 |
| 2025-02-20 | Ma Songjiang (President) | Sale | 2,000 | 12.40 | 24,800 |
| 2025-02-19 | Ma Songjiang (President) | Sale | 2,000 | 12.29 | 24,580 |
| 2025-02-18 | Ma Songjiang (President) | Sale | 2,000 | 12.49 | 24,980 |
| 2025-02-14 | Ma Songjiang (President) | Sale | 2,000 | 11.94 | 23,880 |
| 2025-02-13 | Ma Songjiang (President) | Sale | 2,000 | 11.69 | 23,380 |
| 2025-02-12 | Ma Songjiang (President) | Sale | 2,000 | 11.49 | 22,980 |
| 2025-02-11 | Ma Songjiang (President) | Sale | 1,878 | 11.52 | 21,634 |
| 2025-02-10 | Ma Songjiang (President) | Sale | 2,000 | 11.90 | 23,800 |
| 2025-02-07 | Ma Songjiang (President) | Sale | 2,000 | 12.16 | 24,320 |
| 2025-02-06 | Ma Songjiang (President) | Sale | 2,000 | 12.85 | 25,700 |
| 2025-02-05 | Ma Songjiang (President) | Sale | 2,000 | 12.62 | 25,230 |
| 2025-02-04 | Ma Songjiang (President) | Sale | 2,000 | 11.62 | 23,240 |
| 2025-02-03 | Ma Songjiang (President) | Sale | 2,000 | 11.47 | 22,940 |
| 2025-01-31 | Ma Songjiang (President) | Sale | 2,000 | 11.51 | 23,020 |
| 2025-01-30 | Ma Songjiang (President) | Sale | 2,000 | 11.37 | 22,740 |
| 2025-01-29 | Ma Songjiang (President) | Sale | 2,000 | 11.43 | 22,860 |
| 2025-01-28 | Ma Songjiang (President) | Sale | 2,000 | 11.51 | 23,020 |
| 2025-01-27 | Ma Songjiang (President) | Sale | 2,000 | 11.18 | 22,360 |
| 2025-01-24 | Ma Songjiang (President) | Sale | 2,000 | 10.89 | 21,780 |
| 2025-01-23 | Ma Songjiang (President) | Sale | 2,000 | 10.49 | 20,980 |
| 2025-01-22 | Ma Songjiang (President) | Sale | 2,000 | 10.63 | 21,260 |
| 2025-01-21 | Ma Songjiang (President) | Sale | 2,000 | 10.85 | 21,700 |
| 2025-01-17 | Ma Songjiang (President) | Sale | 2,000 | 10.72 | 21,440 |
| 2025-01-16 | Ma Songjiang (President) | Sale | 2,000 | 10.71 | 21,420 |
| 2025-01-15 | Ma Songjiang (President) | Sale | 2,000 | 10.85 | 21,700 |
| 2025-01-14 | Ma Songjiang (President) | Sale | 2,000 | 10.39 | 20,780 |
| 2025-01-13 | Ma Songjiang (President) | Sale | 56 | 10.10 | 565 |
| 2025-01-10 | Ma Songjiang (President) | Sale | 1,057 | 10.02 | 10,591 |
| 2025-01-07 | Ma Songjiang (President) | Sale | 1,275 | 10.02 | 12,775 |
| 2025-01-06 | Ma Songjiang (President) | Sale | 941 | 10.16 | 9,560 |
| 2025-01-03 | Ma Songjiang (President) | Sale | 1,167 | 11.03 | 12,872 |
| 2025-01-02 | Ma Songjiang (President) | Sale | 2,000 | 12.40 | 24,800 |
| 2024-12-18 | Ma Songjiang (President) | Sale | 2,000 | 11.64 | 23,280 |
| 2024-12-17 | Ma Songjiang (President) | Sale | 2,000 | 11.09 | 22,170 |
| 2024-06-28 | Usman Nassim | Sale | 3,452 | 12.00 | 41,437 |
| 2024-06-28 | Usman Nassim | Option Ex | 3,452 | 6.93 | 23,922 |
| 2024-05-01 | Usman Nassim | Sale | 20,000 | 14.80 | 295,940 |
| 2024-05-01 | Usman Nassim | Option Ex | 20,000 | 6.93 | 138,600 |
| 2024-04-01 | Usman Nassim | Sale | 20,000 | 16.15 | 323,000 |
| 2024-04-01 | Usman Nassim | Option Ex | 20,000 | 6.93 | 138,600 |
| 2024-01-03 | Ma Songjiang (President) | Sale | 833 | 11.85 | 9,871 |
| 2022-08-09 | Blouse Grant E. (Chief Scientific Officer) | Buy | 3,250 | .47 | 1,527 |
| 2022-08-09 | Miller Seline E. (SVP Finance; Interim CFO & PAO) | Buy | 3,250 | .47 | 1,527 |
| 2022-08-09 | Usman Nassim (President & CEO) | Buy | 3,250 | .47 | 1,527 |
| 2022-02-09 | Blouse Grant E. (Chief Scientific Officer) | Buy | 3,250 | .46 | 1,495 |
| 2022-02-09 | Miller Seline E. (SVP Finance; Interim CFO & PAO) | Buy | 3,250 | .46 | 1,495 |
| 2022-02-09 | Usman Nassim (President & CEO) | Buy | 3,250 | .46 | 1,495 |
| 2021-08-09 | Blouse Grant E. (Chief Scientific Officer) | Buy | 1,163 | 3.62 | 4,210 |
| 2021-08-09 | Levy Howard (Chief Medical Officer) | Buy | 639 | 3.62 | 2,313 |
| 2021-08-09 | Usman Nassim (President & CEO) | Buy | 867 | 3.62 | 3,138 |
| 2021-04-05 | Usman Nassim (President & CEO) | Option Ex | 5,000 | 4.63 | 23,150 |
| 2021-02-09 | Levy Howard (Chief Medical Officer) | Buy | 1,670 | 4.81 | 8,032 |
| 2021-02-09 | Usman Nassim (President & CEO) | Buy | 582 | 4.81 | 2,799 |
| 2020-08-10 | Levy Howard (Chief Medical Officer) | Buy | 1,768 | 4.81 | 8,504 |
| 2020-08-10 | Usman Nassim (President & CEO) | Buy | 582 | 4.81 | 2,799 |
| 2020-03-13 | Cai Veronica (Controller) | Buy | 2,000 | 4.11 | 8,220 |
| 2020-03-13 | Richard John P (Director) | Buy | 2,500 | 3.98 | 9,950 |
| 2020-03-13 | Usman Nassim (President & CEO) | Buy | 4,000 | 3.91 | 15,648 |
| 2020-03-04 | Williams Eddie (Director) | Buy | 2,000 | 5.78 | 11,560 |
| 2020-02-25 | Ling Geoffrey M.d. (Director) | Buy | 3,000 | 6.23 | 18,693 |
| 2020-02-25 | Lawlor Augustine (Director) | Sale | 69,401 | 6.10 | 423,484 |
| 2019-05-24 | Richard John P (Director) | Buy | 1,000 | 8.03 | 8,029 |
| 2019-05-21 | Levy Howard (Chief Medical Officer) | Option Ex | 4,400 | 4.63 | 20,372 |
| 2019-05-21 | Usman Nassim (President & CEO) | Option Ex | 4,400 | 4.63 | 20,372 |
| 2018-11-26 | Levy Howard (Chief Medical Officer) | Option Ex | 149 | 4.63 | 689 |
| 2018-11-16 | Levy Howard (Chief Medical Officer) | Sale | 173 | 11.00 | 1,903 |
| 2018-11-16 | Levy Howard (Chief Medical Officer) | Option Ex | 173 | 4.63 | 800 |
| 2018-05-03 | Levy Howard (Chief Medical Officer) | Option Ex | 7,560 | 4.63 | 35,002 |
| 2018-04-04 | Usman Nassim (President & CEO) | Option Ex | 88 | 4.63 | 407 |
| 2018-03-26 | Payne Fletcher (Chief Financial Officer) | Option Ex | 59 | 4.63 | 273 |
| 2018-03-08 | Deerfield Special Situations Fund, L.p. | Sale | 9,317 | 29.52 | 274,991 |
| 2018-03-07 | Deerfield Special Situations Fund, L.p. | Sale | 10,000 | 30.00 | 300,000 |
| 2018-03-06 | Deerfield Special Situations Fund, L.p. | Sale | 52,461 | 30.56 | 1,603,208 |
| 2015-12-17 | Payne Fletcher (Chief Financial Officer) | Buy | 10,000 | 2.00 | 20,000 |
| 2015-12-17 | Hill Stephen A (Director) | Buy | 5,000 | 2.03 | 10,149 |
| 2015-12-17 | Usman Nassim (President & CEO) | Buy | 4,000 | 2.00 | 8,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of GYRE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Gyre Therapeutics, Inc. (symbol GYRE, CIK number 1124105) see the Securities and Exchange Commission (SEC) website.